Minted: - / 5000

3156 Retigabine
b19436d91a96b99aba1f4024002b105d9f84ff261473dd49974419ffeec44acc

Properties

Background

Red
Bottle

Light blue
Cap

Red
Syringe

Yellow
Bubbles
Yes
Drops
No
Label
Heart

Chemistry

Formula
C16H18FN3O2
Carbon
16
Polarity
Neutral

Retigabine (INN) or ezogabine (USAN) is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. It was approved by the European Medicines Agency under the trade name Trobalt on March 28, 2011, and by the United States Food and Drug Administration (FDA), under the trade name Potiga, on June 10, 2011. Production has been discontinued in June 2017.

From Wikipedia, the free encyclopedia. License: CC BY-SA.